HOME >> MEDICINE >> NEWS
Rise in ICSI cycles suggests infertility could be affecting more men than women

Infertility may be becoming more of a man's problem than a woman's problem according to new figures released at the 21st annual conference of the European Society of Human Reproduction and Embryology.

Until now, approximately 40% of infertility cases have been linked to medical problems in men and 40% to medical problems in women, with the remaining 20% due to joint problems.

However, a report from the ESHRE committee that monitors assisted reproduction in Europe, has shown that ICSI (intracytoplasmic sperm injection) overtook conventional IVF techniques as the most commonly used assisted reproductive technology used in Europe in 2002.

There were more than 122,000 ICSI cycles and nearly 113,000 IVF cycles according to figures reported from 24 European countries in 2002. During the time that the committee has been collecting figures, the numbers of ICSI cycles have risen steadily: in 1997 the proportion of ICSI cycles versus IVF cycles was 43.7%; in 2002 it had grown to 52%.

Dr Anders Nyboe Andersen, Head of the Fertility Clinic at the Rigshospitalet at Copenhagen University Hospital, Denmark, and co-ordinator of the ESHRE IVF monitoring committee, said: "We do not really know why ICSI has become more prevalent. There are probably many reasons. One of them could be that the relative causes of infertility are shifting. We see less and less infertility caused by severe tubal problems in women, probably because of better sexual protection due to the risk of AIDS during the last 15 years. But male subfertility seems to be increasing. Perhaps the data on declining sperm quality are true, and maybe environmental factors are playing an increasing role as the planet becomes more polluted and factors that disrupt the endocrine system enter the food chain."

ICSI is a comparatively young assisted reproduction technique; it was developed by Gianpiero Palermo, with the first ICSI baby being born in 1992. Before its introduction tra
'"/>

Contact: Mary Rice
mary@mrcommunication.org
European Society for Human Reproduction and Embryology
22-Jun-2005


Page: 1 2 3

Related medicine news :

1. Web model of influenza-host lifecycles will aid scientists in creating anti-viral drugs
2. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
3. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
4. Study suggests nonpharmaceutical interventions may be helpful in severe influenza outbreaks
5. Study suggests antithrombotics cause more intracerebral hemorrhagic stroke deaths in over-75s
6. Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment
7. Study suggests use of stem cell transplantation is beneficial treatment of type 1 diabetes
8. Shrug off shoulder surgery myth, study suggests
9. Study suggests wearing no-line bifocals slows myopia progression in some children
10. A year of added life more valuable for the young, study suggests
11. Do specialty heart hospitals drive up heart care use? Study suggests the answer is yes

Post Your Comments:
(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: